Exploring Beyond Mu: Nonopioid Analgesics
- PMID: 40675661
- DOI: 10.1016/j.ncl.2025.05.001
Exploring Beyond Mu: Nonopioid Analgesics
Abstract
Pain remains one of the most common reasons patients seek medical care with rates of chronic pain affecting 20.6% of the US population. The polarizing narrative around opioid prescribing has been accompanied by the publishing and revision of several related guidelines. Certainly, a common theme amongst these publications is the importance of nonopioid analgesics as first-line treatments of chronic pain. This underscores the importance for providers to have a sound understanding of analgesic pharmacology when considering patient-centered approaches to pain. This includes consideration of drug-drug interactions, drug-comorbidity interactions, contraindications and metabolism including pathways using the phase 1 cytochrome P450 enzymes.
Keywords: First-line therapies; Musculoskeletal pain; Neuropathic pain; Nonopioid analgesics; Pain pharmacology.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr. Bettinger discloses Consultant fees with Scilex Holding Company and Salix Pharmaceutical Inc. Scientific Advisory Board: PainScript, LLC. Drs. Wegrzyn, Henault and Dean have nothing to disclose. The contents of this work represent the views of the authors and do not represent the views of the Department of Veteran's Affairs or the United States Government.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials